Angiomax is currently approved for patients undergoing percutaneous coronary intervention, commonly referred to as angioplasty. The Medicines Company also noted that new guidelines released by the American College
Selzentry (maraviroc) blocks viral entry into white blood cells, significantly reducing viral load and increasing T-cell counts in treatment-experienced patients infected with a specific type of HIV. The
So far, the independent data safety monitoring board has reviewed blinded data of over 50 patients; there have been no treatment-related serious adverse events or withdrawals, and the
The seven antibiotics are amoxicillin, cephalexin, sulfamethoxazole/trimethoprim, ciprofloxacin (excluding ciprofloxacin XR), penicillin VK, ampicillin and erythromycin (excluding Ery-Tab). These account for almost 50% of the generic pediatric prescriptions
NKTR-061 (inhaled amikacin) would utilize Nektar’s proprietary pulmonary technology to deliver a specially-formulated amikacin, an aminoglycoside antibiotic, for inhalation deep into the lung. “This new development agreement reinforces
Sanctura XR, the once-daily formulation of Sanctura, is a quaternary ammonium compound and belongs to a class of anticholinergic compounds known as muscarinic receptor antagonists. These compounds relax
Mr Engle succeeds Jack Castello, the company’s former president and CEO, who announced his retirement plans earlier this year. Mr Castello will remain with the company as non-executive
Tezampanel is an AMPA/kainate (AK) receptor antagonist that offers a non-opioid, non-vascular and non-serotonergic approach to the management of pain. The company says that it represents a potentially
Upon close of the transaction Avanir received an upfront payment of $42 million, plus $1.9 million in working capital adjustments. Under the terms of the agreement, Avanir could
Leo Pharma is GTC Biotherapeutics’s partner for ATryn in Europe, Canada and the Middle East. The drug is GTC Biotherapeutics’s recombinant form of human antithrombin, which has both
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.